Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial-March 2024-www.financetom.com

Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial

Sep 3, 2024 11:41 PM

Sept 3 (Reuters) - Athira Pharma ( ATHA ) said on

Tuesday its investigative drug failed to meet the main goal in a

mid-to-late stage trial in patients with mild-to-moderate

Alzheimer's disease.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： Vodafone Idea teams up with L&T for trials of 5G-based smart city solutions Next page： Flipkart Diwali Sale: Check out top deals on smartphones, tablets, laptops

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vodafone Idea teams up with L&T for trials of 5G-based smart city solutions

Oct 18, 2021

The companies will collaborate to test and validate 5G use cases built on Internet of Things (IoT), Video AI (Artificial Intelligence) technologies leveraging L&T's Smart City platform - fusion, addressing the challenges of urbanisation, safety and security and offering smart solutions to the citizens.

Flipkart Diwali Sale: Check out top deals on smartphones, tablets, laptops

Oct 18, 2021

The Flipkart Diwali Sale has plenty of offers across a wide variety of categories such as household goods, furniture, clothing, electronics, and more.

Apple's Unleashed event going live today; here’s what to expect

Oct 18, 2021

Apple’s Unleashed event will be begin at 10.30 pm today, October 18, and is expected to feature the launch of the new MacBook Pro and the Mac Mini

Amazon documents reveal it copied products, rigged search results to boost own brand in India: Report

Oct 14, 2021

That Amazon freely exploits the data at its disposal is almost common knowledge now. But the outing of internal papers, which point to one of its biggest markets, India, gives the buzz a different dimension